We have shown the delivery of candidate antigens as a DNA-prime/protein-boost or DNA-prime/MVA-boost preventative vaccine was highly effective in generating protective immunity consisting of parasite- and antigen-specific lytic antibodies and type 1 CD8+ cytotoxic T lymphocytes against challenge infection and chronic disease in mice [14,15]. This evidence concerns the gene CD8A and infection.